Latest news for Avantis U.S. Equity ETF (ARCA:AVUS)

Technology

Financial Services

Consumer Cyclical

Industrials

Healthcare

Energy

Consumer Defensive

Basic Materials

Communication Services

Utilities

Other

Real Estate

The fund invests primarily in a diverse group of U.S. companies across market sectors and industry groups. The fund may invest in companies of all market capitalizations. The fund seeks securities of companies that it expects to have higher returns by placing an enhanced emphasis on securities of companies with smaller market capitalizations and securities of companies with higher profitability and value characteristics. Conversely, the fund seeks to underweight or exclude securities it expects to have lower returns, such as securities of larger companies with lower levels of profitability and less attractive value characteristics. To identify small capitalization companies with higher profitability and value characteristics, the portfolio managers use reported and/or estimated company financials and market data including, but not limited to, shares outstanding, book value and its components, cash flows from operations, and accruals. The portfolio managers define value characteristics mainly as adjusted book/price ratio (though other price to fundamental ratios may be considered). The portfolio managers define profitability mainly as adjusted cash from operations to book value ratio (though other ratios may be considered). The portfolio managers may also consider other factors when selecting a security, including industry classification, the past performance of the security relative to other securities, its liquidity, its float, and tax, governance or cost considerations, among others.

Apple Inc

Microsoft Corp

Nvidia Corp.

Amazon.Com Inc

Meta Platforms, Inc.

Alphabet Inc

Alphabet Holding Company Inc.

Exxon Mobil Corp.

Jpmorgan Chase & Co.

Eli Lilly & Co.

Avantis US Equity ETF

AT&T Inc. (T)

Government

News

Regulations

Tech

Media

ACWI

AVUS

AT&amp;T (T) gets FCC approval to replace old copper home phone lines with wireless technology, expanding 5G network and fiber coverage for growth.

AT&amp;T Gains FCC Approval to Replace Copper Lines With Wireless Tech

Avantis U.S. Equity ETF

"We will work to appropriately enforce the combination patent through its pediatric exclusivity period expiring in July 2025. We will also continue to defend and protect all our important intellectual property and regulatory rights relating to Entresto."

Biotech

Large Cap

Health Care

Legal

General

The US Court Of Appeals For The Federal Circuit Affirms The Validity Of The Novartis' Entresto (Sacubitril/Valsartan) Combination Patent

Lennar expects to distribute to its stockholders one share of Millrose Class A or Class B common stock for each two shares of Lennar Class A or Class B common stock held of record at the close of business on January 21, 2025, as more fully described below. The distribution will take place prior to the opening of trading on February 7, 2025. Persons who acquire&nbsp;Lennar stock after the close of business on the record date will not receive Millrose shares in the spin-off. Lennar anticipates that "when-issued" trading in Millrose Class A common stock on the NYSE will begin on or about February 5, 2025 under the symbol "MRP WI" and Millrose Class A common stock will begin "regular-way" trading on the NYSE on February 7, 2025 under the symbol "MRP."

Reported Friday, Lennar Moves Forward With Millrose Spin-Off; Record Date Set For January 21, Distribution On February 7

BIIB

SAGE

Reported Saturday, Sage Therapeutics Confirms Receipt Of Biogen's Nonbinding $7.22/Share Acquisition Proposal

Reported Saturday, CSX Secures Labor Agreement With BMWED, Covering 42% Of Unionized Workforce

<ul>
<li>-- Strategic Partnership Strengthens Gilead's Inflammation Research Portfolio with the Addition of LEO Pharma's Preclinical Oral STAT6 Program, Including Targeted Protein Degraders --</li>
<li>-- Gilead Will Have Exclusive Global Rights to the STAT6 Program, and LEO Pharma Will Have the Option to Co-Commercialize for Dermatology Indications Outside the U.S. --</li>
<li>-- LEO Pharma to Maintain Global Rights to Topical Formulations of the STAT6 Program in Dermatology --</li>
</ul>

GILD

Reported Saturday, Gilead And LEO Pharma Join Forces To Accelerate Oral STAT6 Development For Inflammation And Dermatology

<ul>
<li>Blue Owl to place logo patches on dozens of athletes competing across the Australian Open, French Open, Wimbledon, and US Open</li>
<li>Jordan Thompson named as Blue Owl's dedicated athlete ambassador for the Australian Open</li>
</ul>

Reported Sunday, Blue Owl Capital Expands Grand Slam Sponsorship, Partners With Jordan Thompson For Australian Open 2025

Dearborn-based Ford Motor Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) sold 51,745 Mustang Mach-E <a href="https://www.benzinga.com/25/01/42801670/mustang-mach-e-spurs-fords-ev-sales-in-q4-after-it-delays-new-vehicle-launch">SUVs in the U.S. </a>last year, trumping the sales numbers of its gas-powered counterpart Mustang for the first time since the EV&#8217;s sales commenced in late 2020.
What Happened: In the last quarter of 2020, Ford sold three units of the electric Mach-E and officially commenced the sales of the EV. In the whole year, the company had sold 61,090 units of the Mustang. 
In every year since Mach-E sales rose while Mustang sales dipped until last year when Mach-E sales trumped the sales of its gas counterpart under the same nameplate. 
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Year</td>
<td>Mustang Mach-E Sales</td>
<td>Mustang Sales</td>
</tr>
<tr>
<td>2020</td>
<td>3</td>
<td>61,090</td>
</tr>
<tr>
<td>2021</td>
<td>27,140</td>
<td>52,414</td>
</tr>
<tr>
<td>2022</td>
<td>39,458</td>
<td>47,566</td>
</tr>
<tr>
<td>2023</td>
<td>40,771</td>
<td>48,605</td>
</tr>
<tr>
<td>2024</td>
<td>51,745</td>
<td>44,003</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Source: Ford</figcaption></figure>
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="370" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/13032212/hOMJj-ford-mustang-mach-e-sales-since-2020-1024x370.png" alt="" class="wp-image-729887" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/13032212/hOMJj-ford-mustang-mach-e-sales-since-2020-1024x370.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/13032212/hOMJj-ford-mustang-mach-e-sales-since-2020-300x108.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/13032212/hOMJj-ford-mustang-mach-e-sales-since-2020-768x277.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/13032212/hOMJj-ford-mustang-mach-e-sales-since-2020.png 1240w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Why It Matters: Ford&#8217;s Mach-E is one of Ford&#8217;s three EVs sold in the U.S. besides the F-150 Lightning pickup truck and the E-transit electric van. 
Last year, Ford sold 97,865 electric vehicles, accounting for merely 4.7% of its overall vehicle sales in the year. 
A majority of Ford&#8217;s sales include combustion engine vehicles and the company has a long <a href="https://www.benzinga.com/news/24/04/38285214/fords-mustang-gallops-into-60th-year-still-a-pony-with-plenty-of-kick">lineup of gas-powered vehicles</a> besides its best-selling F-series truck or its Explorer SUV.
Check out more of Benzinga's Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/tech/25/01/42937389/tesla-hikes-model-3-y-prices-in-canada-by-c1000-after-announcing-price-increase-in-china">Tesla Hikes Model 3, Y Prices In Canada By C$1000 After Announcing Price Increase In China</a></li>
</ul>
Photo courtesy: Ford

Ford Sold More Electric Mustangs Than Gas Mustangs In 2024

JPMorgan Chase &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>) CEO Jamie Dimon offered praise for Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) CEO Elon Musk while sharing insights on American political dynamics in an interview.
What Happened: &#8220;He&#8217;s clearly an extraordinary talent,&#8221; Dimon said of Musk, citing achievements at Tesla and SpaceX. The banking executive dismissed concerns on CBS&#8217;s 60 Minutes <a href="https://www.youtube.com/watch?v=2REdbQasKX4">interview</a> about Musk&#8217;s influence on right-wing European politics, comparing it to historical precedents like Charles Lindbergh, an American aviator, military officer, and author&#8217;s political involvement.
&#8220;I mean, to look at Tesla and SpaceX — and his attitude is, &#8220;Yeah, well, we should make government more efficient.&#8221; Is this the way to do it? I don't know. Do I want him to succeed? Absolutely,&#8221; Dimon said.
Dimon, who heads America&#8217;s largest bank, expressed &#8220;cautious pessimism&#8221; about the economy despite positive indicators including lower unemployment and cooling inflation. 
When asked if he was surprised by President-elect Donald Trump&#8216;s 2024 election victory, Dimon responded with a simple &#8220;no.&#8221; He attributed Trump's success to widespread public frustration with government inefficiency and the perceived condescension in social policy approaches.
&#8220;People were angry at what they call the &#8216;state,&#8217; you know, the swamp, ineffective government,&#8221; Dimon told interviewer Lesley Stahl. &#8220;They didn&#8217;t want to be lectured to on social policies continuously.&#8221;
See Also: <a href="https://www.benzinga.com/personal-finance/25/01/42932900/elon-musks-ex-wife-and-mother-to-his-5-kids-says-his-secret-to-extreme-success-is-working-harder-than-average-bear-and-saying-no-a-lot">Elon Musk&#8217;s Ex-Wife And Mother To His 5 Kids Says His Secret To Extreme Success Is Working Harder Than &#8216;Average Bear&#8217; And Saying &#8216;No&#8217; A Lot</a>
Why It Matters: The comments come after previous speculation about Dimon&#8217;s potential role in the Trump administration. JPMorgan in October clarified that Dimon &#8220;has not endorsed anyone&#8221; after Trump <a href="https://www.benzinga.com/general/politics/24/10/41192406/jamie-dimon-rejects-trump-endorsement-claim-casting-doubt-on-treasury-rumors">claimed otherwise on Truth Social</a>. 
The denial casts doubt on earlier reports that Trump was considering Dimon for Treasury Secretary, especially given Trump&#8217;s historical preference for political loyalists in cabinet positions.
During his tenure at JPMorgan, Dimon has maintained a pragmatic stance on political matters while focusing on economic issues and banking sector stability. Under his leadership, JPMorgan Chase has grown to become the largest U.S. bank by assets, with significant influence in global financial markets.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/personal-finance/25/01/42898261/bill-and-melinda-gates-say-they-raised-their-3-daughters-with-a-middle-class-upbringing-youre-not-allowed-to-tell-people-how-we-flew">Bill And Melinda Gates Say They Raised Their 3 Daughters With A &#8216;Middle-Class&#8217; Upbringing–&#8217;You&#8217;re Not Allowed to Tell People How We Flew …&#8217;</a></li>
</ul>
Image Via Flickr 
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

Equities

Markets

TSLA

Jamie Dimon Calls Elon Musk 'An Extraordinary Talent' — JP Morgan CEO Shares Why Trump's Election Victory Didn't Surprise Him

Orbit Phase 3 study of setrusumab in osteogenesis imperfecta continuing to planned second interim analysis, expected in mid-2025
Alvelestat, for Alpha-1 Antitrypsin Deficiency-associated Lung Disease, receives positive EMA opinion on European Orphan Designation Application; European Commission expected to issue final decision in first quarter 2025

MREO

Reported Sunday, Mereo BioPharma Reports Progress In Setrusumab Phase 3 Study For OI And Awaits EMA Decision On Alvelestat Orphan Designation

FY 2024 revenue of ~$611 million and Q4 2024 revenue of ~$165 million, representing 9% growth sequentially

Reported Sunday, 10x Genomics Reports $610.8M In 2024 Revenue (-1% YoY), $165M Q4 Revenue (-10% YoY), And $393M In Cash Reserves

Tesla Inc. CEO Elon Musk endorsed calls for Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) to release its content moderation communications with government officials, responding &#8220;That would be good&#8221; to prominent tech investor Dave Lee&#8216;s demand for transparency.
What Happened: &#8220;If Zuck is serious then let&#8217;s see the <a href="https://www.benzinga.com/government/22/12/30119008/elon-musks-twitter-files-part-6-drops-company-acted-as-fbis-subsidiary-a-one-big-happy-family-vibe">equivalent of the Twitter Files</a> for Facebook. Show all the communication back and forth (not just handpicked ones) between the government and Facebook regarding COVID/vaccine censorship,&#8221; Lee wrote on X, drawing Musk&#8217;s support.
The Twitter Files were a <a href="https://www.benzinga.com/news/22/12/29949435/twitter-files-revealed-musk-reacts-to-exposure-of-company-response-to-hunter-biden-story">series of internal Twitter documents </a>that were released in 2022–2023 by journalists and authors.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">That would be good <a href="https://t.co/Fkmj5ctjr5">https://t.co/Fkmj5ctjr5</a>
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1878693613313663295?ref_src=twsrc%5Etfw">January 13, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
The exchange comes as Meta CEO Mark Zuckerberg announced plans to adopt a feature similar to X&#8217;s Community Notes, signaling a major shift in <a href="https://www.benzinga.com/25/01/42851889/meta-ditches-fact-checking-for-community-notes-zuckerberg-says-opportunity-to-restore-free-expression">content moderation strategy</a>. During a video announcement, Zuckerberg acknowledged past censorship mistakes and outlined plans to &#8220;get back to our roots around free expression on Facebook and Instagram.&#8221;
Meta&#8217;s internal data reveals the scope of <a href="https://www.benzinga.com/tech/25/01/42779753/mark-zuckerbergs-meta-replaces-global-affairs-chief-nick-clegg-with-republican-joel-kaplan-ahead-of-trump-inauguration">current moderation practices</a>, with Joel Kaplan, the company&#8217;s new head of global affairs, disclosing that 10-20% of December&#8217;s content removals may have been erroneous. The platform&#8217;s pivot includes phasing out third-party fact-checkers and relocating trust and safety teams <a href="https://www.benzinga.com/25/01/42851889/meta-ditches-fact-checking-for-community-notes-zuckerberg-says-opportunity-to-restore-free-expression">from California to Texas</a>.
See Also: <a href="https://www.benzinga.com/markets/equities/25/01/42938119/lockheed-martin-donates-1m-to-trumps-inaugural-committee-as-speculation-grows-over-elon-musk-led-doge-crackdown-on-traditional-defense-contracts">Lockheed Martin Donates $1M To Trump&#8217;s Inaugural Committee As Speculation Grows Over Elon Musk-Led DOGE Crackdown On Traditional Defense Contracts</a>
Why It Matters: The changes follow Zuckerberg&#8217;s recent $1 million donation to President-elect Donald Trump&#8216;s inauguration fund and their November meeting at Mar-a-Lago. During a Joe Rogan podcast appearance, Zuckerberg detailed past tensions with President Joe Biden&#8216;s administration officials, describing instances where they &#8220;would call up our team and, like, scream at them and curse&#8221; over <a href="https://www.benzinga.com/25/01/42931361/mark-zuckerberg-says-biden-officials-berated-meta-staff-as-they-refused-to-remove-true-content-it-just-got-to-this-pointthats-ridiculous">content removal requests</a>.
X CEO Linda Yaccarino praised Meta&#8217;s decision, calling it a &#8220;smart move by Zuck&#8221; and suggesting other <a href="https://www.benzinga.com/25/01/42851889/meta-ditches-fact-checking-for-community-notes-zuckerberg-says-opportunity-to-restore-free-expression">platforms would follow</a>. 
The platform&#8217;s transformation includes adding three <a href="https://www.benzinga.com/25/01/42851889/meta-ditches-fact-checking-for-community-notes-zuckerberg-says-opportunity-to-restore-free-expression">new board members</a>, including Trump ally Dana White, indicating strategic alignment with the incoming administration and a marked departure from its previous content moderation approach during the COVID-19 pandemic and 2020 election cycle.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/global/25/01/42938329/us-reportedly-probes-barriers-subsidies-and-unfair-trade-practices-by-china-in-global-shipbuilding-as-trump-tariff-threat-looms">US Reportedly Probes Barriers, Subsidies And Unfair Trade Practices By China In Global Shipbuilding As Trump Tariff Threat Looms</a></li>
</ul>
Image Via Shutterstock 
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Social Media

Elon Musk Urges Mark Zuckerberg To Release Facebook Files, Calls It 'Good' After Meta Adopts X's Community Notes-Like Feature

<ul>
<li>New biomarkers on track for commercial launch in January 2025</li>
<li>Preliminary financial results indicate record full-year revenue and AVISE CTD trailing twelve-month ASP, with improvements to adjusted EBITDA and cash burn</li>
</ul>

Reported Earlier, Exagen Expects $55.3M-$55.8M In Annual Revenue (+33% YoY), And Narrowed EBITDA Loss Of $9.8M–$10.8M In 2024; For Q4 Sees $13.3M-$13.8M In Revenue

<ul>
<li>Revenue of $1,021.8 Million Grows 0.9% --</li>
<li>-- Revenue Increases 1.0% on Constant Currency Basis, In-Line with Guidance –</li>
<li>– GAAP and Non-GAAP EPS Expected to be Near High End of Guidance Ranges –</li>
</ul>

HOLX

Reported Earlies, Hologic Reports Preliminary Q1 FY25 Revenue Of $1.02B (+0.9% YoY), EPS Expected Near High-End Of Guidance

With U.S. stock futures trading lower this morning on Monday, some of the stocks that may grab investor focus today are as follows:
<ul>
<li>Wall Street expects Comtech Telecommunications Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMTL#NASDAQ">CMTL</a>) to report a quarterly loss at 16 cents per share on revenue of $125.53 million before the opening bell, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. Comtech Telecommunications shares gained 3.9% to $4.29 in after-hours trading.</li>
<li>WD-40 Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDFC#NASDAQ">WDFC</a>) posted better-than-expected results for its first quarter and reiterated its FY25 guidance on Friday. WD-40 shares gained 5.5% to $254.00 in the after-hours trading session.</li>
<li>Analysts are expecting KB Home (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KBH#NYSE">KBH</a>) to post quarterly earnings at $2.45 per share on revenue of $1.99 billion. The company will release earnings after the markets close. KB Home shares gained 0.1% to $63.25 in after-hours trading.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<ul>
<li>Nordstrom Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JWN#NYSE">JWN</a>) said total company net sales rose 4.9%, while comparable sales increased 5.8% for the nine-week holiday period ended Jan. 4. The company also said it sees comparable sales growth of 2.5% to 3.5% versus 52 weeks in fiscal 2023, up from its previous guidance of 1.0% to 2.0% growth. Nordstrom shares gained 0.2% to $24.05 in the after-hours trading session.</li>
<li>Analysts expect ServiceTitan Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTAN#NASDAQ">TTAN</a>) to post a quarterly loss at 3 cents per share on revenue of $198.52 million after the closing bell. ServiceTitan shares gained 0.1% to $101.40 in after-hours trading.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/25/01/42923396/wall-streets-most-accurate-analysts-weigh-in-on-3-real-estate-stocks-with-over-7-dividend-yields-2">Wall Street&#8217;s Most Accurate Analysts Weigh In On 3 Real Estate Stocks With Over 7% Dividend Yields</a></li>
</ul>
Photo courtesy: Shutterstock

Earnings

Pre-Market Outlook

Trading Ideas

CMTL

TTAN

WDFC

WD-40 Company, KB Home And 3 Stocks To Watch Heading Into Monday

<h3>Companies Reporting Before The Bell</h3>
• Comtech Telecom (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMTL#NASDAQ">CMTL</a>) is estimated to report quarterly loss at $0.36 per share on revenue of $125.53 million. 
<h3>Companies Reporting After The Bell</h3>
• Calamos Glb Total (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGO#NASDAQ">CGO</a>) is estimated to report quarterly earnings at $2.88 per share on revenue of $770.40 million. 
• ServiceTitan (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTAN#NASDAQ">TTAN</a>) is projected to report earnings for its third quarter. 
• KB Home (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KBH#NYSE">KBH</a>) is likely to report quarterly earnings at $2.47 per share on revenue of $1.98 billion. 
• Aehr Test System (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEHR#NASDAQ">AEHR</a>) is expected to report quarterly earnings at $0.03 per share on revenue of $15.04 million. 
• Educational Development (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EDUC#NASDAQ">EDUC</a>) is expected to report earnings for its third quarter. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AEHR

EDUC

Earnings Scheduled For January 13, 2025

<ul>
<li>– Full Year 2024 Preliminary Net Product Revenues of $1,646 Million for ONPATTRO&#xAE;, AMVUTTRA&#xAE;, GIVLAARI&#xAE;, and OXLUMO&#xAE;, Representing 33% Annual Growth –</li>
<li>– 2025 Combined Net Product Revenue Guidance&#x2A;&#x2A; of $2,050 Million to $2,250 Million Positions Company to Achieve Alnylam P5x25 Goal of Non-GAAP Profitability –</li>
<li>– Robust Clinical Pipeline with Multi-Billion-Dollar Opportunities for Sustainable Growth –</li>
</ul>

ALNY

Reported Earlier, Alnylam Pharmaceuticals Preliminary Results: $1.6B In 2024 Net Product Revenue (+33% YoY); 2025 Revenue Guidance Of $2.05B–$2.25B, And Highlights Key Pipeline Goals

<ul>
<li>-- Updating peak systemic&nbsp;mastocytosis franchise revenue opportunity to $4 billion, catalyzed by strong AYVAKIT&#xAE; (avapritinib) launch and evolving SM prevalence estimates --</li>
<li>&nbsp;-- Expect to achieve $2 billion in AYVAKIT revenue by 2030 --</li>
<li>-- BLU-808 demonstrates wide therapeutic window with rapid, robust and sustained&nbsp;tryptase reductions exceeding 80% in Phase 1 healthy volunteer study --</li>
</ul>

BPMC

Reported Earlier, Blueprint Medicines Sees AYVAKIT 2024 Revenue At $475M–$480M (+130% YoY); Projects $4B SM Franchise Opportunity, Targets $2B AYVAKIT Revenue By 2030;

<ul>
<li>– Cabozantinib franchise achieves approximately $1.805 billion in preliminary U.S. net product revenues for fiscal year 2024 –</li>
<li>– Fiscal year 2025 net product revenues guidance of $1.95 billion - $2.05 billion –</li>
<li>– Presentation and webcast at 43rd Annual J.P. Morgan Healthcare Conference tomorrow, Monday, January 13th at 5:15 p.m. PT / 8:15 p.m. ET –</li>
</ul>

EXEL

Reported Earlier, Exelixis Reports $2.165B In Preliminary 2024 Revenue, Projects $2.15B-2.25B In 2025, And Highlights Pipeline Progress

Ahead of President Joe Biden&#8216;s departure from office, a U.S. investigation has concluded that China engages in unfair&nbsp;practices to dominate the global&nbsp;shipbuilding industry. 
What Happened: The probe, initiated by&nbsp;U.S. Trade Representative Katherine Tai&nbsp;in April, was requested by the United Steelworkers and other&nbsp;unions under Section 301 of&nbsp;the Trade Act of 1974. This revelation could lead to potential penalties against China, according to&nbsp;Reuters&nbsp;on Monday. 
Investigators found that China uses&nbsp;financial support, barriers for foreign&nbsp;firms, forced technology transfer, and intellectual property theft to gain an advantage in shipbuilding, a source told Reuters. The report also highlights China&#8217;s suppression of labor costs in the maritime and logistics sectors. The findings could lead to&nbsp;tariffs or port fees on&nbsp;Chinese-built vessels.
The report indicates that China&#8217;s share in&nbsp;the $150 billion global shipbuilding&nbsp;market has grown from 5% in 2000&nbsp;to over 50% in 2023, largely due to government subsidies. Meanwhile, U.S. shipbuilders&#8217; market share has fallen below 1%. The U.S. Trade Representative&#8217;s office is expected to release the findings later this week, just before President Biden leaves office on Jan. 20.
This investigation follows previous&nbsp;efforts by the Biden administration&nbsp;to curb China&#8217;s influence through tariffs and export controls. Experts suggest that rebuilding the U.S. shipbuilding industry will require substantial investment and time.
Why It Matters: The U.S. probe into China&#8217;s shipbuilding practices has sparked significant controversy. Last year, the Chinese Ministry of Commerce <a href="https://www.benzinga.com/news/24/04/38312330/mistake-on-top-of-a-mistake-china-slams-us-probe-into-its-maritime-and-shipbuilding-sectors">criticized the investigation</a>, calling it a &#8220;mistake on top of a mistake,&#8221; asserting that China&#8217;s industrial growth is driven by technological innovation and market competition. 
Additionally, China is projected to surpass the <a href="https://www.benzinga.com/news/24/10/41142611/china-set-to-surpass-us-in-advanced-military-manufacturing-by-2035-report">U.S. in advanced technology </a>and military manufacturing by 2035, as reported by the South China Morning Post. Former vice-chairman of the National People&#8217;s Congress, Lu Yongxiang, emphasized that the decline of U.S. manufacturing is irreversible, suggesting a rapidly diminishing competitive edge for the U.S.
Meanwhile, Chinese policymakers are reportedly considering <a href="https://www.benzinga.com/economics/macro-economic-events/24/12/42473889/china-eyes-yuan-devaluation-to-counter-trumps-tariffs-will-it-work">allowing yuan devaluation</a> in 2025 to counter the economic impact of Trump&#8217;s proposed potential 60% tariff on Chinese imports.
Read More:
<ul>
<li><a href="https://www.benzinga.com/tech/25/01/42931758/apple-staring-at-market-share-decline-in-china-amid-declining-iphone-shipments-top-analyst-flags-why-some-models-could-be-face-shipping-momentum-challenges">Apple Staring At Market Share Decline In China Amid Declining iPhone Shipments: Top Analyst Flags Why Some Models Could Be Face Shipping Momentum Challenges</a></li>
</ul>
Disclaimer: This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.
Image via Shutterstock

Global

US Reportedly Probes Barriers, Subsidies And Unfair Trade Practices By China In Global Shipbuilding As Trump Tariff Threat Looms

<ul>
<li>2024 Total Revenue of $528M, Representing Significant Growth of 32% Year-Over-Year1</li>
<li>Strong and Growing Demand for Galafold&#xAE; and Pombiliti&#xAE; + Opfolda&#xAE;</li>
<li>Total Revenue Growth of 17-24% at CER Expected in 2025</li>
<li>&gt;3,000 People Treated with an Amicus Therapy Today2</li>
</ul>

FOLD

Reported Earlier, Amicus Reported $528M In 2024 Revenue (+32% YoY), Projects 17-24% Growth In 2025, And Highlights First Full Year Of Pombiliti + Opfolda Sales

Avantis U.S. Equity ETF declares quarterly distribution of $0.3266

Taking Stock: Q4 2024 Equity Market Outlook

Risks Without Rewards

Monthly Market Recap: September's Surprise Surge

Dancing In September, A Fed Cut To Remember

Q3 2024 Active Management Review: Market Leadership Reverses

Monthly Market Recap: Post-Election Positioning

The Enduring Advantage

AVUS: Broad Market Exposure With Low Valuation

GMO Q3 2024 Quarterly Letter

ACSI

ACTV

ACVF

ACWV

AESR

AFLG

AFMC

AFSM

AFTY

AGGY

ANEW

APRT

APRW

ARKF

ARKK

ARKQ

ARKW

ARKX

ARTY

ASET

ASHR

ASHS

AVIG

AVUV

BAPR

BBAG

BBMC

BBSC

BBUS

BCHG

BFOR

BIBL

BITO

BKAG

BKLC

BKMC

BKSE

BLCN

BLES

BLOK

BMAR

BMAY

BMVP

BNDC

BOUT

BTGD

BUYZ

BUZZ

BWVTF

CALF

CATH

CBON

CBSE

CHGX

CHIQ

CIBR

CLOU

CMBS

CNXT

CNYA

CQQQ

CRBN

CXSE

DAPP

DDIV

DEEP

DEMZ

DEUS

DFAS

DFAU

DGRS

DGRW

DIVS

DRAG

DSTL

DTEC

DUSA

DVLU

DVOL

DWAS

DWLD

DYNF

EAGG

ECNS

EFIV

EQAL

EQWL

ESGA

Comments

Avantis U.S. Equity ETF

News

Latest news for Avantis U.S. Equity ETF (ARCA:AVUS)

Tuesday, December 24, 2024

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga